Clinical trial Recruiting at 1 site Observational Ages 18 and up

Neocement® Inject P for dental bone augmentation and regeneration.

Official title: Evaluation of the Safety and Performance of the Neocement® Inject P: A Prospective Observational Study in Dental Area

Run by Bioceramed · NCT07179510 · Data updated 2026-11-12

This study will try Neocement® Inject P, an injectable calcium‑phosphate bone substitute, in adults having reconstructive dental or maxillofacial surgery to see if it is safe and helps bone heal.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment66 (estimated)
SponsorBioceramed
Industry-sponsored
Drugs / interventionsradiation
Locations1 site (Lisbon)
StatusRecruiting
StartedOctober 6, 2025
Main results expectedOctober 2027
Study endsOctober 2027
Registry record updatedJune 18, 2026
Trial IDNCT07179510 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (≥18 years) scheduled for reconstructive dental or maxillofacial surgery with non‑load‑bearing bone defects and no active infection, metabolic contraindication, or known material hypersensitivity.

Probably not a fit

Patients with active local or systemic infection, metabolic bone disease, unstable or load‑bearing implantation sites, or known hypersensitivity to the implant materials are unlikely to benefit from this device.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a prospective observational study collecting real‑world clinical data on the performance and safety of Neocement® Inject P when used according to its intended indications in dental and maxillofacial procedures. The device is an injectable, single‑use calcium phosphate and chitosan bone substitute delivered as a two‑part system intended to fill non‑load‑bearing bony voids and support bone regeneration. Adult patients undergoing reconstructive dental surgery who provide informed consent will have device handling, clinical outcomes, and adverse events recorded under a predefined observational protocol. The collected data will serve as clinical evidence to inform the device's clinical evaluation.

Why it matters

Potential benefit: If successful, Neocement® Inject P could improve bone quality and accelerate bone healing after dental reconstructive procedures.

How similar studies have gone: Injectable calcium‑phosphate bone substitutes similar to Neocement® Inject P have clinical precedent with documented bone healing and acceptable safety profiles in comparable indications.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adult males or females (age \> 18 years old);
* Patients who are able to sign an informed consent form (for data collection);
* Patients undergoing reconstructive dental surgery and indicated for the use of Neocement® Inject P;

Exclusion Criteria:

* Patients who are unable to understand consent and the objectives of the study;
* Signs of local or systemic acute/ active or chronic infections;
* Metabolic affections;
* Severe degenerative diseases, conditions in which general bone grafting is not advisable;
* Implementation sites that allow product migration;
* Conditions which require structural support in the skeletal system;
* Conditions where the implantation site is unstable and not rigidly fixated;
* Sensibility to the implantable materials;
* Known hypersensitivity to the implant material.

Where it's running

  • Egas Moniz School of Health and Science
    Lisbon, Portugal
    Recruiting

Study contacts

  • Principal investigator: João Botelho — Egas Moniz School of Health and Science Caparica, Lisboa, Portugal
  • Study coordinator: Alexandre Barros
  • Email: info@bioceramed.com
  • Phone: 253 573 460

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.